Histogen Inc. (HSTO) Financial Statements (2026 and earlier)

Company Profile

Business Address 10655 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,2599,65812,10914,55212,59817,848
Cash and cash equivalent7,2599,65812,10914,55212,59817,848
Restricted cash and investments300300400400400400
Receivables  2399748867
Inventory, net of allowances, customer advances and progress billings    616161
Inventory    616161
Prepaid expense6414637079661,222483
Other current assets61887793120391
Other undisclosed current assets1376641925386,521
Total current assets:8,27410,60813,45616,33815,02725,771
Noncurrent Assets
Operating lease, right-of-use asset 4,4924,5764,6584,7384,8164,451
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization 360398436473510527
Other noncurrent assets416469523638692748
Total noncurrent assets:5,2685,4435,6175,8496,0185,726
TOTAL ASSETS:13,54216,05119,07322,18721,04531,497
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6851,0709771,3829062,656
Taxes payable✕✕✕✕83✕✕
Employee-related liabilities✕✕✕✕145✕✕
Accounts payable3944413825615341,274
Accrued liabilities2916295955933721,382
Deferred revenue191919191919
Other undisclosed current liabilities 265251238(3)212200
Total current liabilities:9691,3401,2341,3981,1372,875
Noncurrent Liabilities
Long-term debt and lease obligation  354,4514,5134,574
Finance lease, liability  358911
Liabilities, other than long-term debt4,3084,3864,458848994
Deferred revenue697479848994
Operating lease, liability 4,2394,3124,3794,4434,5044,563
Total noncurrent liabilities:4,3084,3894,4634,5354,6024,668
Total liabilities:5,2775,7295,6975,9335,7397,543
Temporary equity, including noncontrolling interest      4,296
Equity
Equity, attributable to parent9,29411,35414,40517,28016,32920,675
Common stock555555
Additional paid in capital103,124103,092102,673102,58498,03798,995
Accumulated deficit(93,835)(91,743)(88,273)(85,309)(81,713)(78,325)
Equity, attributable to noncontrolling interest(1,029)(1,032)(1,029)(1,026)(1,023)(1,017)
Total equity:8,26510,32213,37616,25415,30619,658
TOTAL LIABILITIES AND EQUITY:13,54216,05119,07322,18721,04531,497

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues554553,755
Other undisclosed gross profit   (61)   
Gross profit:55(57)553,755
Operating expenses(2,093)(3,479)(2,972)(3,603)(3,399)(4,438)
Other undisclosed operating income   61   
Operating loss:(2,088)(3,474)(2,968)(3,598)(3,394)(683)
Nonoperating income (expense)(1)11(1) (1)
Investment income, nonoperating (1)11(1) (1)
Other nonoperating expense      
Other undisclosed loss from continuing operations before equity method investments, income taxes   (1)   
Loss from continuing operations:(2,089)(3,473)(2,968)(3,599)(3,394)(684)
Loss before gain (loss) on sale of properties:✕✕✕✕(3,599)(3,394)(684)
Other undisclosed net income (loss)  1   
Net loss:(2,089)(3,473)(2,967)(3,599)(3,394)(684)
Net income (loss) attributable to noncontrolling interest(3)333611
Net loss attributable to parent:(2,092)(3,470)(2,964)(3,596)(3,388)(673)
Preferred stock dividends and other adjustments     (488) 
Net loss available to common stockholders, diluted:(2,092)(3,470)(2,964)(3,596)(3,876)(673)

Comprehensive Income ($ in thousands)
Annual | Quarterly

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(2,089)(3,473)(2,967)(3,599)(3,394)(684)
Comprehensive loss:(2,089)(3,473)(2,967)(3,599)(3,394)(684)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(3)333611
Comprehensive loss, net of tax, attributable to parent:(2,092)(3,470)(2,964)(3,596)(3,388)(673)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: